StockData
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31

CASI Pharmaceuticals, Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$0.10+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

CASI Pharmaceuticals, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

CASI Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.